Laparoscopic highly selective vagotomy

Area of Science:

• Gastroenterology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Gastroduodenal ulcers affect 10% of the population, with medical treatments having high recurrence rates (50-70%).
• Recurrent or treatment-resistant ulcers necessitate alternative therapeutic strategies.
• This study addresses surgical options for patients with persistent or recurring gastroduodenal ulcers.

Purpose of the Study:

• To evaluate the efficacy and safety of laparoscopic highly selective vagotomy (HSV) for gastroduodenal ulcers.
• To assess the impact of laparoscopic HSV on patient recovery and hospital stay.
• To establish HSV as a primary surgical treatment for specific ulcer patient cohorts.

Main Methods:

• Thirty-three patients underwent laparoscopic highly selective vagotomy (HSV) between April 1992 and March 1993.
• Pre-operative assessments included gastroscopy, isotopic gastric studies, and selection tests for chronic peptic ulcer disease.
• Patients were evaluated post-operatively using the Visick grading system and gastric acid output measurements.

Main Results:

• Laparoscopic HSV was technically feasible in 100% of cases, including those with prior surgery or peritonitis.
• No intra-operative complications, conversions, mortality, or morbidity were reported.
• Mean hospital stay was 2 days for elective cases and 7 days for perforated ulcer cases, with significant reductions in basal and maximal acid output.

Conclusions:

• Highly selective vagotomy (HSV) is the recommended surgical treatment for gastroduodenal ulcers.
• The laparoscopic approach for HSV significantly reduces hospital stay and enhances patient comfort.
• Laparoscopic HSV provides a safe and effective solution for managing recurrent and chronic peptic ulcer disease.